Loading...
XSTOIZAFE B
Market cap5mUSD
Dec 23, Last price  
0.21SEK
1D
2.88%
1Q
10.31%
Jan 2017
-97.29%
IPO
-92.07%
Name

iZafe Group AB

Chart & Performance

D1W1MN
XSTO:IZAFE B chart
P/E
—
P/S
32.30
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
60.97%
Rev. gr., 5y
-24.79%
Revenues
2m
+149.93%
3,75026,41939,1015,698000155,0007,571,00014,328,0008,904,000442,000729,0001,822,000
Net income
-32m
L+36.76%
-5,907,245-4,941,580-2,917,935-7,228,886-3,170,867-2,596,712-6,356,026-4,269,000-11,312,000-23,116,000-12,754,000-39,277,000-23,526,000-32,174,999
CFO
-11m
L-47.54%
-1,621,933-941,317-829,552-1,772,786-4,316,036-3,719,000-1,410,000-15,319,000-24,567,000-33,493,000-21,457,000-11,256,000

Profile

iZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
URL
https://izafe.se/
IPO date
Apr 04, 2011
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,822
149.93%
729
64.93%
442
-95.04%
Cost of revenue
4,656
3,506
24,677
Unusual Expense (Income)
NOPBT
(2,834)
(2,777)
(24,235)
NOPBT Margin
Operating Taxes
(3,541)
(60)
3,002
Tax Rate
NOPAT
707
(2,717)
(27,237)
Net income
(32,175)
36.76%
(23,526)
-40.10%
(39,277)
207.96%
Dividends
Dividend yield
Proceeds from repurchase of equity
18,567
8,004
50,702
BB yield
-27.82%
-34.40%
-135.51%
Debt
Debt current
1,037
1,139
1,090
Long-term debt
4,011
6,382
4,984
Deferred revenue
333
Other long-term liabilities
372
(333)
Net debt
(786)
5,820
(12,652)
Cash flow
Cash from operating activities
(11,256)
(21,457)
(33,493)
CAPEX
(2,659)
(214)
Cash from investing activities
(1,457)
(2,510)
(214)
Cash from financing activities
16,846
6,942
49,885
FCF
2,664
(1,992)
(30,447)
Balance
Cash
5,834
1,701
18,726
Long term investments
Excess cash
5,743
1,665
18,704
Stockholders' equity
(105,630)
(92,816)
(29,172)
Invested Capital
133,879
135,698
74,885
ROIC
0.52%
ROCE
EV
Common stock shares outstanding
231,755
79,953
46,249
Price
0.29
-1.03%
0.29
-64.03%
0.81
-72.76%
Market cap
66,746
186.88%
23,266
-37.82%
37,416
-63.87%
EV
65,960
29,086
24,764
EBITDA
17,025
1,588
(19,388)
EV/EBITDA
3.87
18.32
Interest
240
182
3,002
Interest/NOPBT